Introduction: Malignant pleural mesothelioma (MPM) is a malignancy with a very poor prognosis for which new treatment options are urgently needed. We have previously shown that dendritic cell (DC) immunotherapy provides a clinically feasible treatment option. In the current study. we set out to assess the immunological changes induced by DC immunotherapy in peripheral blood of MPM pat... https://www.marketingjeunesse.com/product-category/6nw-brandy/